Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study

O3-04-01: Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: Results from an 18-month multi-center phase 3 trial

(2008) Robert C. Green et al.   Alzheimers & Dementia

O3-04-07: Tau aggregation inhibitor (TAI) therapy with rember™ arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks

(2008) Claude M. Wischik et al.   Alzheimers & Dementia

Effect of infarcts on dementia in the Baltimore longitudinal study of aging

(2008) Juan C. Troncoso et al.   ANNALS OF NEUROLOGY

Brain reserve and the prevention of dementia

(2008) Michael J Valenzuela   CURRENT OPINION IN PSYCHIATRY

Vascular risk factors and Alzheimer’s disease

(2008) David F Cechetto et al.   Expert Review of Neurotherapeutics

Patterns and stages of  -synucleinopathy: Relevance in a population-based cohort

(2008) J. Zaccai et al.   NEUROLOGY